ArticleRheumatology advances in practice2024

Real-world experience of IL-17Ai drug survival in a large cohort of axial spondyloarthritis and psoriatic arthritis.

Jake Weddell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.